Evolution of acquired haemoglobin H disease monitored by capillary electrophoresis: a case of a myelofibrotic patient with a novel ATRX mutation
Marco Rosetti,Giovanni Poletti,Rosa Catapano,Silvia Trombetti,Michela Grosso,Sauro Maoggi,Giovanni Ivaldi,Evita Massari,Marta Monti,Melania Olivieri,Valentina Polli,Alice Clementoni,Tommaso Fasano
DOI: https://doi.org/10.1515/cclm-2024-0452
2024-06-13
Clinical Chemistry and Laboratory Medicine (CCLM)
Abstract:We would like to thank all the technical staff for their unconditional support and Thaddeus Moustrides for English editing. Research ethics: Not applicable. Informed consent: Not applicable. Author contributions: The authors have accepted responsibility for the entire content of this manuscript and approved its submission. Marco Rosetti designed the study, performed the research, analysed the data, drafted the paper, approved the submitted version of the paper. Giovanni Poletti analysed the digital patient's data, designed the study. Rosa Catapano and Silvia Trombetti performed the molecular analysis and analysed these data. Michela Grosso contributed to the molecular analysis interpretation and drafted the paper. Sauro Maoggi verified the CE data and drafted the paper. Giovanni Ivaldi verified the data and drafted the paper. Evita Massari analysed the data, contributed with digital CE analysis. Marta Monti analysed the data, drafted the paper. Melania Olivieri and Valentina Polli contributed with microscopy analysis. Alice Clementoni analysed the digital patient's data. Tommaso Fasano drafted the paper and revised it critically, approved the submitted version of the paper. Competing interests: The authors state no competing interests. The authors alone are responsible for the content and writing of this article. Sauro Maoggi is Scientific Affairs Manager in Sebia-Italia. Research funding: None declared. Data availability: Not applicable. 1. Kalle, KI, Lai, MI, Md Noor, S. Non-deletional alpha thalassaemia: a review. Orphanet J Rare Dis 2020;15:166. https://doi.org/10.1186/s13023-020-01429-1. Search in Google Scholar 2. Forget, BG. De novo and acquired forms of alpha thalassemia. Curr Hematol Rep 2006;5:11–4. Search in Google Scholar 3. Ratnakumar, K, Duarte, LF, LeRoy, G, Hasson, D, Smeets, D, Vardabasso, C, et al.. ATRX-mediated chromatin association of histone variant macroH2A1 regulates α-globin expression. Genes Dev 2012;26:433–8. https://doi.org/10.1101/gad.179416.111. Search in Google Scholar 4. Steensma, DP, Gibbons, RJ, Higgs, DR. Acquired alpha-thalassemia in association with myelodysplastic syndrome and other hematologic malignancies. Blood 2005;105:443–52. https://doi.org/10.1182/blood-2004-07-2792. Search in Google Scholar 5. Jones, JA, Broszeit, HK, LeCrone, CN, Detter, JC. An improved method for detection of red cell hemoglobin H inclusions. Am J Med Technol 1981;47:94–6. Search in Google Scholar 6. Higgs, DR, Wood, WG, Barton, C, Weatherall, DJ. Clinical features and molecular analysis of acquired hemoglobin H disease. Am J Med 1983;75:181–91. https://doi.org/10.1016/0002-9343(83)91189-0. Search in Google Scholar 7. Catapano, R, Russo, F, Rosetti, M, Poletti, G, Trombetti, S, Sessa, R, et al.. Identification of a novel ATR-X mutation causative of acquired α-thalassemia in a myelofibrosis patient. Egypt J Med Hum Genet 2024;25:25. https://doi.org/10.1186/s43042-024-00497-3. Search in Google Scholar 8. Herbaux, C, Duployez, N, Badens, C, Poret, N, Gardin, C, Decamp, M, et al.. Incidence of ATRX mutations in myelodysplastic syndromes, the value of microcytosis. Am J Hematol 2015;90:737–8. https://doi.org/10.1002/ajh.24073. Search in Google Scholar 9. Wang, C, Shi, Y. Acquired alpha thalassemia associated with myeloid malignancy: a systematic literature review. Leuk Res 2021;111:1066–70. https://doi.org/10.1016/j.leukres.2021.106670. Search in Google Scholar © 2024 Walter de Gruyter GmbH, Berlin/Boston
medical laboratory technology